Hundreds of people who may have been in contact with eight individuals infected with Ebola virus in Guinea’s southern prefectures of Nzérékoré and Macenta have been vaccinated with the experimental Ebola vaccine in a bid to contain the latest flare-up of Ebola.
Vaccination of Ebola contacts in Guinea. Courtesy of WHO Guinea/Lancei Touré
Hundreds of people who may have been in contact with eight individuals infected with Ebola virus in Guinea’s southern prefectures of Nzérékoré and Macenta have been vaccinated with the experimental Ebola vaccine in a bid to contain the latest flare-up of Ebola.
The World Health Organization (WHO)’s office in Guinea says more than 1,000 contacts have been identified and placed under medical observation. Nearly 800 have been vaccinated over the past week, including 182 who are considered to be high-risk contacts.
The VSV-EBOV vaccine currently being administered was found to be highly effective in preventing Ebola infection in a large trial conducted by Guinea’s Ministry of Health, WHO and partner agencies last year. It has since been used in Sierra Leone to contain a recent flare-up there, and now, once again, in Guinea.
The “ring vaccination” strategy involves vaccinating anyone who has come into contact with a person infected with Ebola, as well as contacts of theirs.
In this latest flare-up, there have been eight cases of Ebola and seven deaths since late February. The most recent case, an 11-year-old girl, is being treated at an Ebola care facility in Nzérékoré and as of today, is reported to be in a stable condition. Six of the deceased are from three generations of the same extended family in the village of Koropara Centre.
Local health authorities reactivated the emergency coordination mechanism that was in place during the height of the Ebola epidemic in Nzérékoré and a large-scale inter-agency response is in progress.
WHO has a team of 75 staff members working in the affected areas to support the government-led response, including epidemiologists, surveillance experts, contact tracers, vaccinators, social mobilizers and infection prevention and control experts. WHO has also dispatched two top-level Ebola-experienced clinicians to assist at the Ebola treatment center in Nzérékoré.
Households under medical monitoring are receiving a range of assistance from partner agencies, including food packages, hygiene kits and cash stipends to purchase additional items.
Infection prevention and disease control measures, including a public awareness campaign and other health promotion and community engagement activities, are taking place in the affected areas.
Tests from blood samples of the confirmed cases indicate that this latest cluster of Ebola stems from a known transmission chain and not a new chain introduced by the animal population.
Both Nzérékoré and Macenta have been hard hit by Ebola in the West Africa outbreak. In the sub-prefecture of Koropara, at the center of this latest flare-up, there were 24 Ebola cases, 15 deaths and 9 survivors between October and December of 2014.
This re-emergence of Ebola in Guinea is the first since the original outbreak in the country was declared over on Dec. 29, 2015. WHO has continuously stressed that flare-ups like this one should be anticipated, largely due to virus persistence in some survivors, and that the three Ebola-affected countries must maintain strong capacity to prevent, detect and respond to further outbreaks.
Source: WHO
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.